Ironwood Pharmaceuticals inc (IRWD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IRWD Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Ironwood Pharmaceuticals inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent220.47
Cash & Short-term Investments220.00
Accounts receivable105.84
Prepaid Expense And Other Assets Current5.98
Total Current Assets332.29
Equipment/Property/Plant Net3.17
Intangible Assets1.84
Other Assets, Noncurrent97.27
Operating Lease Right Of Use Asset8.90
Total Assets434.57
Liabilities
Accounts Payable, Current AC3.24
Convertible Debt, Current LO199.86
Other Liabilities, Current33.22
Total Current Liabilities236.31
Long-term debt385.00
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt385.00
Operating Lease Liability Current3.27
Accrued Expenses And Other Liabilities Current27.90
Operating Lease Liability Noncurrent9.23
Total Liabilities651.71
Stockholders' Equity
Common Stock Value0.17
Additional Paid In Capital Common Stock1,416.43
Retained Earnings / Accumulated Deficit-1,632.95
Other Equity-0.80
Common Stockholder's Equity-217.14
Total Stockholder's Equity-217.14
Liabilities & Stockholder's Equity434.57
4 historic quarters locked

Sign in to unlock the full Ironwood Pharmaceuticals inc balance sheet history.

About Ironwood Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-091987

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.